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Abstract: Infection is a very important but rare cause of scleritis, occurring in about 5%–10% 
of all patients presenting with scleral inflammation. However, due to the similarity of its 
presentation, infectious scleritis is often initially managed as autoimmune, potentially further 
worsening its outcome. The overall visual outcome in infectious scleritis is generally worse 
than its autoimmune counterparts, perhaps because of the delay in diagnosis or because of 
the aggressive nature of associated microbes. Thus, there is a definite need for insight into the 
diagnostic approach and treatment options for this ocular disease process. Several studies and 
case reports have been published in recent years that have provided useful information regarding 
the presenting clinical features and etiologic microbial agents in infectious scleritis. This review 
summarizes the important findings in the literature that may aid in differentiating infectious 
scleritis from other etiologies, including predisposing factors, microbe-specific characteristics, 
diagnostic tools, treatment modalities, and outcomes.
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Background
Scleritis is a state of ocular inflammation with a wide spectrum of clinical presentations 
and etiologic factors (Table 1). Specific etiologies of scleritis, varying from idiopathic 
to autoimmune to infectious, portend variable disease severity and outcome. Infection 
is an important but rare cause of the scleritis, occurring in about 5%–10% of all cases.1 
However, due to the similarity of its presentation, infectious scleritis is often initially 
managed as autoimmune, potentially worsening its outcome. The overall visual outcome 
in infectious scleritis is generally worse than its autoimmune counterparts, perhaps 
because of this delay in diagnosis or because of the aggressive nature of associated 
microbes. Recent studies have identified specific inciting factors for infectious scleritis. 
Not surprisingly, these factors are typically surgery, most commonly pterygium surgery 
but also excisions of conjunctival neoplasms, cataract surgery, vitreoretinal surgeries, 
and glaucoma surgeries.2–4 Paula et al and Hodson et al report that the use of concomi-
tant radiation or mitomycin C is also a risk factor.2,5 Trauma, especially with introduction 
of organic material to the ocular surface or self-inoculation from a distant site on the 
body is also a significant inciting factor.6 In isolated cases, immunosuppression due to 
human immunodeficiency virus or chemotherapy, may be a risk factor for spontane-
ous cases of infectious scleritis.2,7,8 Interestingly, Meyer et al reported an individual 
case of spontaneous infectious scleritis without any such prior history that revealed 
Pseudomonas aeruginosa resistant to 4th generation fluoroquinolones, indicating the 
importance of considering infectious etiologies despite the lack of leading history.9Clinical Ophthalmology 2013:7 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
2114
Ramenaden and Raiji
While postoperative worsening of scleritis has been well 
reported in those with preexisting autoimmune scleritis, a 
concomitant infectious etiology is much less common. The 
similarities in presentation between autoimmune and infec-
tious scleritis often delays diagnosis. Infectious scleritis 
after pterygium surgery with adjunctive β-radiation and 
mitomycin C has been well established.2,11,12 Several reasons 
may exist for this association. Meallet proposed in 2006 that 
the use of adjunctive therapies such as these are likely to com-
promise the integrity of episcleral conjunctival vessels and 
underlying tissue, thus inhibiting adequate wound healing and 
leaving the sclera vulnerable to infection. He further hypoth-
esizes that surgical techniques such as leaving bare sclera 
exposed or excessive use of cautery, as well as poor contact lens 
hygiene or nonhealing epithelial defects may all   contribute.12 
P . aeruginosa, the most common agent in infectious scleritis, 
utilizes neutrophil-activated collagenases to destroy tissue, 
especially when sclera is left bare. Other microbes have 
similar biochemical mechanisms by which they are able to 
infiltrate ocular tissues.12 Furthermore, traditional antibiotic 
regimens, both topical and systemic, remain inadequate due 
to the avascularity of the sclera and the dense structure of 
collagen fibers, limiting tissue penetration.12 Additionally, 
the misdiagnosis of infectious scleritis as a postoperative 
inflammatory complication leads to initial aggressive local 
and systemic corticosteroid therapy that further worsens their 
infection and may lead to poor visual outcomes.
Another known characteristic of infectious scleritis is 
its sometimes delayed presentation, occurring months to 
years after ocular surgery or trauma. Jain et al proposed that 
conjunctival and tear film alterations may expose underly-
ing necrotic scleral collagen to microorganisms and allow 
localization, adherence, colonization and invasion.1 Microbes 
can then remain dormant within the sclera for years without 
inciting an inflammatory response, making the diagnosis of 
infectious scleritis in these cases quite difficult. It remains 
unclear why these infections may be reactivated after such 
long periods of latency.12
According to one large retrospective study by Hodson 
et al, the median age of the patients at diagnosis of infec-
tious scleritis is 70 years old.2 Most studies reveal an older 
population, suggesting that age may hold some significance 
in the diagnosis of infectious scleritis.2,13,14 Additionally, the 
time from an identifiable inciting event to the presentation of 
scleritis can range in 0 days up to 36 years, generally longer 
in postsurgical patients than the post-nonsurgical trauma 
patients, with the longest latency period reported occurring 
after a history of pterygium surgery.2,10
In all cases of infectious scleritis, P . aeruginosa is the 
most common infectious agent.1,2 Additional identified 
microbes include Nocardia, Aspergillus, Fusarium,   Candida, 
Beauveria, Stenotrophomonas, Streptococcus, Staphylococ-
cus aureus (especially of the methicillin-resistant type), 
Serratia, Enterobacter, Achromobacter, Propionibacterium, 
Haemophilus, Alcaligenes, mycobacteria, and herpes viridae. 
In some cases, coinfections have been reported.2,15 Although 
P . aeruginosa as well as other bacterial and viral etiologies 
are most common in developed countries, fungi and Nocardia 
are relatively more prevalent in developing countries, perhaps 
due to humid climates and increased exposure to soil.1
Retinal surgeries such as vitrectomy, scleral buckling 
with intrascleral fixation, and epiretinal membrane peel 
procedures have been associated with acid-fast organisms, 
such as   Mycobacterium chelonae, more so than anterior seg-
ment procedures.2,16 These retinal surgeries have additionally 
been associated with Pseudomonas, methicillin-resistant 
Staphylococcus aureus, and coagulase-negative Staphylo-
coccus albus.3,17 The use of sub-Tenon’s triamcinolone ace-
tonide injection has also been associated with the development 
of infectious scleritis in two cases, which were culture positive 
for Staphylococcus epidermidis and Nocardia.18,19
Presentation
Infectious scleritis may present with certain clinical patterns 
that might facilitate more efficient diagnosis when recognized. 
Table 1 Types of scleritis
Anterior-diffuse Greater than 50% contiguous scleral 
involvement. Associated with systemic 
disease. Generally in women 40–70 years 
old or men 30–60 years old. Rare in the 
young and the very old.
Anterior-nodular Distinct nodules present. Associated with 
isolated disease. Both sexes generally 
involved, 40–60 years old.
Anterior-necrotizing  
(with inflammation)
Scleral necrosis with scleromalacia. 
Associated with systemic disease. 
Generally in women in their 40s.
Anterior-necrotizing 
(without inflammation)
Scleral necrosis without scleromalacia. 
Usually associated with systemic disease. 
Generally in women, 35–75 years old.
Posterior scleritis Usually associated with anterior scleritis. 
Generally in women in their 60s. Diagnosis 
made using clinical and ultrasound findings.
infectious scleritis Generally necrotizing. Can have anterior 
and posterior involvement. Scleral ulcers 
with calcific plaque at the base and 
microabscesses. Tissue extension beyond 
obvious clinical findings.*
Notes: *Though infectious scleritis can present in many ways, these are the unique 
clinical findings found most commonly in this review. Data from Raiji et al,45 and 
watson and Hayreh.46Clinical Ophthalmology 2013:7 submit your manuscript | www.dovepress.com
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Furthermore, because the prevalence of certain microbes in 
infectious scleritis varies by environment, inciting event, or 
sometimes even by symptomology, knowledge of this infor-
mation may allow faster microbial identification.
Similar to patients with autoimmune scleritis, patients 
with infectious scleritis commonly present with symptoms 
of redness, pain, and epiphora.13 Infectious scleritis after 
retinal surgery tends to be associated with more rapid and 
extreme pain than anterior segment surgeries.3 The most 
common clinical signs at presentation in a retrospective 
study of 55 patients with infectious scleritis included epis-
cleral and conjunctival hyperemia (98%) and scleral necro-
sis (93%),2 noted consistently in other studies as well.1,12,13 
In this large study, 19 eyes had isolated scleritis whereas 
37 involved adjacent ocular structures, including the cornea 
and extraocular muscles, both spreading primarily from the 
sclera to elsewhere or secondarily to the sclera.2 An anterior 
chamber reaction of greater than 1+ cell is usually present 
at the initial encounter.20,21 Endophthalmitis has also been 
documented as the presenting finding.1,11,13,22 Not surpris-
ingly, retinal surgeries predisposed patients with infectious 
scleritis to posterior scleral thickening and retinal or choroidal 
detachments.3,16,17,21
More notably, patients with infectious scleritis may 
present with a scleral ulcer at sites of prior tissue pen-
etration, at times including satellite abscesses or involving 
extraocular muscles, which may mimic orbital inflammatory 
syndrome.1,13,21 Calcified plaques are often found at the base 
of scleral ulcers (Figure 1).1,21 Unifocal or multifocal scleral 
abscesses are consistently reported, appearing as distinctly 
yellowish nodules under intact conjunctiva (Figure 2).1,13,23 
Abscesses are characteristically scattered superiorly or infe-
riorly along an arc of 3–4 mm from the limbus (Figure 3).21 
A black arc-shaped band from the initial ulcer site through 
subsequent abscesses has been identified in some patients after 
resolution, indicating a track of disseminated infection.21
Necrotizing scleritis tends to be the most common 
presentation of infectious scleritis. A necrotizing pattern is 
also seen in association with autoimmune scleritis with or 
without vasculitis or metabolic disorders, all of which require 
immunosuppression for treatment and would worsen visual 
outcome in infectious scleritis (Figure 4).1,15 Thus, infectious 
etiologies should be suspected in any case of progressive 
indolent necrosis with suppuration, refractory to anti-
inflammatory regimens.1 Mild to moderate pain is generally 
associated with diffuse and nodular scleritis whereas severe 
pain is more frequently associated with necrotizing scleritis,24 
Figure 1 Scleral ulcer with calcific plaque.
Notes: (A) At presentation, there was a calcific plaque over the scleral ulcer bed 
(arrowhead). The ulcer progressed and became contiguous with a corneal infiltrate 
(arrow). (B) Multiple new nodules (arrowheads) from which P. aeruginosa was 
cultured, appeared on the 22nd day of hospitalization. ©1998 BMJ Publishing Group. 
Reproduced with permission from Hsiao CH, Chen JJ, Huang SC, Ma HK, et al. 
intrascleral dissemination of infectious scleritis following pterygium excision. Br J 
Ophthalmol. 1998;82(1):29–34.21
Figure 2 Slit lamp pictures depicting different clinical presentation.
Notes: (A) Case no 2: multiple scleral abscess. (B) Case no 12: single scleral 
abscess. (C) Case no 4: necrotic ulcer (post cataract surgery). (D) Case no 3: two 
punched out ulcers. Reproduced with permission from Kumar SS, Das S, Sharma S 
et al. Clinico-microbiological profile and treatment outcome of infectious scleritis: 
experience from a tertiary eye care eye center of india. Int K Inflam. 2012:753560.13Clinical Ophthalmology 2013:7 submit your manuscript | www.dovepress.com
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suggesting that pain out of proportion to examination findings 
may be indicative of a possible infectious etiology.
Other ocular complications noted at the time of presenta-
tion of infectious scleritis are decreased vision, peripheral 
keratitis presenting as interstitial keratitis or thinning with 
ulceration, or glaucoma.2,20
For the purposes of this review, infectious agents that have 
not been shown in the literature to cause primary scleritis 
were excluded.
Diagnosis
In two large retrospective reviews done in the United States 
and Taiwan, the majority of cases of infectious scleritis were 
found to be bacterial, with fewer cases being fungal.2,22 In 
developing countries, however, fungal etiologies are more 
common, likely related to differences in climate and envi-
ronmental exposures.1,13
In general, fungal, nocardial and mycobacterial infec-
tions take longer to diagnose than bacterial infections.2 It 
is recommended that a complete diagnostic work-up of 
infectious etiologies include scleral scrapings and culture 
on blood and chocolate agar, brain–heart infusion broth, 
thioglycolate broth, nonnutrient agar with E. coli overlay, and 
Sabouraud dextrose agar.1 Diagnosis of viral etiologies like 
herpes-related scleritis can be confirmed by scleral biopsy 
and the use of immunofluorescence, as well as positive titers 
or signs of chronic herpetic infection like corneal hypoes-
thesia.14,20 Kumar et al advocate scleral scrapings in every 
case of suspected infectious scleritis that does not respond 
to initial antibiotics, not only for the purpose of diagnosis 
but also to debulk necrotic tissue and improve antimicrobial 
penetration.13
In addition to cues from clinical presentation, history, and 
slit-lamp examination, the use of ancillary testing has been 
proposed to be of diagnostic value in infectious scleritis. 
Nguyen and Yiu comment on the utility of ultrasound bio-
microscopy in allowing early detection of scleritis-associated 
retinal and choroidal detachments.25 Ultrasound biomicros-
copy is further used to demonstrate anterior ciliary body rota-
tion and elimination of the ciliary sulcus in infectious scleritis 
along with a diffuse lacy-appearing choroidal thickening.25 
Additionally, they suggest that optical coherence tomography 
allows the visualization of small vitreoid opacities and abnor-
mal subretinal deposits, which may represent lipofuscin-laden 
macrophages in infectious scleritis (Figure 5).25
Su et al performed a prospective study in which they found 
that elevated erythrocyte sedimentation rate and C-reactive 
protein were noted in 9 of 12 patients with infectious scleritis.10 
While these general inflammatory parameters can be elevated in 
any case of inflammation, in these patients, both of these values 
returned to normal with treatment of the infection.10 Addition-
ally, these patients underwent a thorough laboratory work-up 
to document the lack of any associated underlying autoimmune 
state that could have explained these laboratory findings.
Microbe-specific findings
Bacterial etiologies comprise the majority of cases of infec-
tious scleritis.5 Bacterial proteins may contribute to tissue 
damage via proteases and activation of tissue complement 
pathways.5 Pseudomonas aeruginosa represents about 85% 
of cases of bacterial scleritis.5 Thus, most findings discussed 
Figure 3 Case 1: Scleral thinning from original ulcer through subsequent abscess 
extended in an arc shape.
Note: © 1998 BMJ Publishing Group. Reproduced with permission from Hsiao CH, 
Chen JJ, Huang SC et al.  Intrascleral dissemination of infectious scleritis following 
pterygium excision. Br J Ophthalmol. 1998;82(1):29–34.21
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Figure 4 Visual acuities before and after treatment.
Notes: Patients with infectious necrotizing scleritis had the poorest BCVA before 
and after treatment. The data are presented as the mean ± standard deviation. 
Reproduced with permission from Ahn SJ, Oh JY, Kim MK, Lee JH, Wee WR. 
Clinical features, predisposing factors, and treatment outcomes of scleritis in the 
Korean population. Korean J Ophthalmol. 2010;24(6):331–335.15
Abbreviations: BCVA, best corrected visual acuities; logMAR, logarithmic value of 
the minimal angle of resolution.Clinical Ophthalmology 2013:7 submit your manuscript | www.dovepress.com
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in relevant studies are largely in the context of   Pseudomonas 
scleritis. Though these findings are generally shared by most 
infectious etiologies, there are certain characteristics or out-
comes associated with microbes other than Pseudomonas 
that may be indicative of other etiologies.
Staphylococcus aureus is also an established cause of 
bacterial scleritis. As reported by Arora et al, S. aureus 
scleritis presented as a pyomyositis with an inverse hypopyon 
and localized scleral thinning in a patient with a large thigh 
abscess.26 Lee et al reported a case of methicillin-resistant 
S. aureus 6 months after pterygium excision that was initially 
misdiagnosed clinically as Pseudomonas and was unrespon-
sive to systemic amikacin and ceftazidime as well as topical 
ciprofloxacin. They suggest that MRSA should be suspected 
when typical postoperative antibiotics are ineffective.27
Streptococcus pneumoniae is a common infectious 
agent in children and the elderly with concomitant joint, 
cardiovascular, gastrointestinal, and genitourinary infections. 
Recently, this bacteria has been associated with infectious 
scleritis after pterygium surgery with concurrent use of 
β-irradiation or mitomycin C.5,11 Paula et al reported a case 
of S. pneumoniae scleritis that presented with mucopurulent 
discharge, vascular congestion, and three scleral abscesses 
with necrosis and a small aqueous fistula in the upper sclera 
at the site of pterygium excision. This case responded well 
to topical ciprofloxacin and intravenous cephatholin as well 
as oral diclofenac.5 Altman et al discussed four cases of S. 
pneumoniae scleritis that were treated with intravenous and 
topical antibiotics, two of which had full resolution and good 
visual outcome and two that had more devastating outcomes. 
One of these latter patients developed endophthalmitis 
requiring enucleation and one developed scleral perforation 
requiring a corneoscleral graft with resulting count fingers 
visual outcome.11 Therefore, S. pneumoniae represents a 
potentially aggressive form of infectious scleritis.
Stenotrophomonas maltophilia is a rare aerobic nonfer-
mentative Gram-negative bacterium that is difficult to treat. 
Lin et al reported a case of S. maltophilia-associated infec-
tious scleritis that occurred 18 years after pterygium surgery.28 
Ramos-Esteban and Jeng reported a case of S. maltophilia 
scleritis in which ultrasound biomicroscopy revealed a 
dome-shaped mass over an area of a partial-thickness scleral 
laceration after minor ocular trauma.29 In one particular case, 
full resolution seemingly occurred after fortified topical and 
systemic antibiotics as well as surgical debridement and patch 
grafting. Interestingly, however, 5 months after resolution, 
this patient presented with intrascleral dissemination of 
the same infection, indicating the importance of long-term 
follow-up and the possibility of microinvasion greater than 
clinically detectable.28
Mycobacterium tuberculosis scleritis is rare. The myco-
bacteria itself can cause an immune-mediated inflammatory 
microangiopathy and may indirectly lead to an inflamma-
tory scleritis.1 Kesen et al reported a case of a 54-year-old 
woman with 6 months of eye pain and nodular scleritis 
unresponsive to steroids and methotrexate. She was found 
to be QuantiFERON® gold–positive with hilar granulomas 
on CT, but due to initial lack of response to quadruple 
tuberculosis therapy and a bronchoalveolar lavage negative 
for acid fast bacilli, the regimen was abruptly discontinued 
and immunosuppression was restarted. She later presented 
with scleral rupture and polymerase chain reaction of the 
specimen at that time revealed the M. tuberculosis genome.30 
Mycobacterial infections other than tuberculosis (MOTT) 
have a low incidence in humans but present in a disseminated 
form in immunocompromised patients. These microbes 
are known to be difficult to isolate by common laboratory 
techniques and are easily confused with other pathogens. 
Therefore, they should be suspected in immunocompromised 
patients with +AFB (acid-fast bacilli) or granulomatous 
noncaseating inflammation.31 M. chelonae is among these 
MOTT species and has been shown to cause scleritis.31 M. 
Figure 5 Advanced imaging studies of complications of infectious scleritis.
Notes: (A) 35 MHz immersion ultrasound biomicroscopy demonstrating shallow 
anterior  chamber,  thickened  and  anteriorly  rotated  ciliary  body  (arrow),  and 
elimination of the ciliary sulcus. (B) Thickened episcleral, scleral, and choroidal 
tissues  are  evident  in  the  magnified  view.  (C)  10  MHz  B-scan  ultrasonography 
showing  double  retinal  and  choroidal  detachment,  L-12  view,  (D)  L-mac  view, 
and (E) spectral optical coherence tomography showing vitreous clumps (dotted 
arrows  and  circles),  subretinal  fluid,  and  subretinal  precipitates  (solid  arrow).
Reproduced with permission from Nguyen P, Yiu SC. Imaging studies in a case of 
infectious scleritis after pterygium excision. Middle East Afr J Ophthalmol. 2012;19(3): 
337–339.25
Abbreviations: L-12, longitudinal-12 view; L-mac, longitudinal-macular view.Clinical Ophthalmology 2013:7 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
2118
Ramenaden and Raiji
chelonae is a quick-growth mycobacteria easily confused 
with Nocardia or M. fortuitum that requires several tissue 
samples to adequately differentiate, thereby delaying diag-
nosis and treatment. It is known to be resistant to typical 
antituberculous drugs. Treatment must be continued for 4 
weeks to 6 months after full resolution of clinical signs, 
although due to the rarity of this diagnosis, the exact time 
of treatment has not yet been established.31
Lepromatous leprosy, another mycobacterium-related 
disease, has been reported to present with unilateral ocular 
involvement as interstitial keratitis and granulomatous ante-
rior uveitis. In one report by Poon et al, an initial response was 
achieved using antileprotics and anti-inflammatory agents; 
however, the patient went on to develop recurrent episodes 
of scleritis that necessitated multiple scleral patch grafts 
for scleral thinning, subsequently requiring enucleation. 
Histology failed to demonstrate lepromatous infection, but 
showed chronic nongranulomatous scleritis.32
Toxoplasma gondii, an obligate intracellular parasitic 
protozoan, is usually associated with posterior intraocular 
inflammation; however, it has been reported by Schuman 
et al to cause scleritis in five cases.33 Two of those patients 
were diagnosed clinically and treated successfully with 
medical therapy. Three of the patients, two of whom were 
immunosuppressed, went undiagnosed without treatment 
for toxoplasmosis, and progressed to eventually require 
enucleation. Thus, T. gondii, while rare, should be suspected 
in scleritis with associated retinochoroiditis, especially in 
those who are immunosuppressed.33
Although herpes infections of the eye, both HSV and VZV , 
have predominantly been thought of in relation to the cornea 
and ocular adnexa, they have also been reported in cases of 
infectious scleritis.14 Gonzalez-Gonzalez et al conducted a 
large retrospective study of patients with herpetic scleritis 
and found a predominance of middle-aged females with 
unilateral findings and moderate to severe pain.20 The acu-
ity of the presentation of herpes scleritis can be   variable. 
While one study reports acute onset,20 another reports 
chronic herpes-associated inflammation with an average of 
3.2 years of symptoms prior to diagnosis.14 Herpetic scleritis 
is more likely to be of the diffuse anterior type than of the 
nodular or necrotizing type.20 Perilimbal devascularization 
with peripheral corneal thinning along with a significant 
amount of associated uveitis are findings associated with 
herpetic scleritis, with significantly greater vision loss noted 
in herpes than in idiopathic cases of scleritis.14 In general, 
herpes infections are not associated with posterior scleritis, 
vitreoretinal involvement, or scleromalacia perforans.14,20 
Herpetic scleritis has similar rates of increased intraocular 
pressure when compared to idiopathic types.20 Interestingly, 
systemic symptoms are generally not present in patients with 
herpetic scleritis, and the central cornea tends to be spared.14 
This lack of typical corneal findings in herpetic scleritis 
generally delays its diagnosis; therefore, a high index of sus-
picion should exist when the previously discussed symptoms 
and signs are noted.20 Definitive diagnosis can be made by 
immunohistopathological analysis of scleral biopsies, clinical 
evidence of dendritic or stromal keratitis, or positive anti-HSV 
or anti-VZV titers.20 Herpetic scleritis typically responds 
quickly to acyclovir treatment, within 3–8 weeks,14,20 with 
the inflammation generally lasting from 5–32 months.14 The 
initial dosage of acyclovir used in these studies was 800 mg 
five times daily,14,20 with most patients requiring a lower 
maintenance dose of acyclovir to prevent recurrence, which 
typically occurs at the same site as previous inflammation.14 
Previous treatment with immunosuppressive therapy can 
prolong and worsen herpetic scleral inflammation.14
Fungal scleritis, unlike bacterial and viral scleritis, has 
worse overall outcomes (Table 2).1,34 Jain et al report that 
fungal scleritis is more commonly encountered in hot, humid 
climates, generally following surgical or accidental trauma.1 
In cases of fungal scleritis, full thickness corneal inflamma-
tion contiguous with scleral lesions is quite common.1 In 
their study, patients with fungal scleritis progressed despite 
treatment, to develop rapidly progressive cataracts, serous 
retinal or choroidal detachments, phthisis, or endophthalmi-
tis, of which a majority progressed to evisceration.1
Jain et al further report that Aspergillus and Nocardia 
are the most common fungal agents in infectious scleritis.1 
Fincher and Fulcher recovered Aspergillus fungal hyphae 
from a biopsy of a scleral nodule in one patient with a 
known history of intravenous drug abuse.35 This infection 
was successfully treated with intravenous caspofungin as 
Table 2   Comparison  of  fungal  cases  with  other  infectious 
scleritis cases
Fungal scleritis Others
Total number 8 13
Associated corneal  
infiltration
3/8 (40%) 4/13 (30%)
Multifocal scleral abscess 3/8 (40%) 0
endophthalmitis 3/8 (40%) 0
eviscerated 4/8 (50%) 0
Useful vision 1/8 (13%) 
(95% CI, 0%–36%)
6/13 (46%) 
(95% CI, 19%–63%)
Note: Microbial scleritis – experience from a developing country. © 2008 Nature 
Publishing Group. Reproduced with permission from: Jain V, Garg P, Sharma S. Microbial 
scleritis-experience from a developing country. Eye (Lond). 2009;23(2):255–261.1Clinical Ophthalmology 2013:7 submit your manuscript | www.dovepress.com
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well as repeated surgical drainage of all emerging scleral 
abscesses.35 Nocardia is much more common in agricultural 
societies, where exposure to soil or plant matter is prevalent, 
as compared with other infectious etiologies.1,34 Generally, 
Nocardia does not cause fulminant infection; however, in 
the presence of immunosuppression such as oral steroids 
the presentation can be devastating, and can progress 
to ocular infection and even involve the central nervous 
system.36 In addition to the common findings in scleritis 
of ocular pain, redness, and blurred vision, patients with 
Nocardia-related scleritis have nodular lesions that present 
as pointed abscesses.34 Nocardia should be suspected when 
scleral inflammation does not respond to intensive first-line 
antibiotic therapy.36 Direct smear is usually unrevealing; 
diagnosis of Nocardia is more easily made with Gram stain 
or acid-fast stain.34 One case of Nocardia scleritis showed 
full resolution with debridement and systemic trimethoprim/
sulfamethoxazole,37 but it has also been shown to have very 
good sensitivity to amikacin.36
Other rare fungi have been documented to cause scleritis. 
Pseudallescheria boydii, a saprophytic fungus frequently 
isolated from agricultural soil and polluted water, has been 
reported to present with extensive involvement of the pos-
terior sclera with abscesses.38 Paecilomyces lilacinus is an 
environmental mold found in soil and vegetation that rarely 
causes human infection. Chung et al discussed a case of 
P . lilacinus that presented as multiple scleral abscesses with 
fibrinoid anterior chamber reaction that then progressed 
to involve the cornea despite topical and oral antifungals. 
Debridement and intracameral injection of amphotericin B 
was required for resolution 4 months later, although it resulted 
in phthisis and light perception vision.39 Lastly, Scedosporium 
prolificans, an emerging opportunistic fungus, was found 
to cause late-onset scleritis with a median presentation of 
7.6 years after pterygium excision. Jhanji et al reported that 
voriconazole is the most effective medical therapy for S. 
prolificans scleritis, although it only allowed resolution in six 
of nine cases.40 Thus, it is evident that overall visual prog-
nosis in fungal scleritis is generally poor, possibly because 
of delayed diagnosis, poor penetration of antifungals into 
avascular sclera, nonavailability of fungicidal agents, or the 
ability of organisms to persist in avascular scleral tissue for 
long periods of time without inciting inflammatory response, 
allowing progressive worsening.1
Treatment
It has been suggested repeatedly that prevention of infectious 
scleritis is most important for patient outcome. Avoiding 
overuse of cautery and adjunctive therapy during surgical 
procedures may spare the episcleral blood flow and allow bet-
ter wound healing and resistance to infection.21 Most studies 
advocate the avoidance of bare sclera techniques that leave 
the ocular surface vulnerable to infection. However, in one 
study by Tittler et al the use of amniotic membrane over an 
area of debridement was discouraged, suggesting that it pro-
vides maximum exposure for topical antibiotics and prevents 
the incubated microbes from staying at the site, with adequate 
re-epithelialization occurring shortly after debridement.41 If 
a bare sclera technique is chosen, close follow-up should be 
undertaken with examination for scleral ischemia, the first 
sign of which should prompt conjunctival autografting or 
other scleral reinforcement.21
One large study of patients with infectious scleritis by 
Hodson et al employed various antimicrobial treatment 
regimens: 95% topical, 77% oral, and 11% intravitreal 
therapy. Despite a mean treatment duration of 50 days, 
medical therapy was adequate as the sole treatment in only 
18% of patients, with most requiring surgical debridement.2 
A higher rate of enucleation or evisceration was present in 
those treated solely with medical methods.42 Cryotherapy, 
lamellar or penetrating corneoscleral grafts, or removal of 
hardware in addition to intensive antibiotics improves overall 
outcomes in patients.2,43 Early and repetitive surgical debride-
ment is heavily advocated in multiple studies.1,13,22,41,42 Tittler 
et al showed a 100% globe preservation rate, best corrected 
vision of 20/120 to 20/400, fewer complications, and shorter 
hospital stays with prompt surgical debridement at diagnosis 
(within 2.5 days).41 Most significantly, it has been shown in 
multiple studies that the inflamed area is often found intra-
operatively to be much larger than clinically judged by slit 
lamp exam (Figure 6).1,13,21,22 Furthermore, there is sometimes 
a notable tunnel lesion of scleral ulcer and small pockets 
of abscess within necrotic sclera that require very careful 
exploration. Some patients require a scleral patch graft due 
to the large area of resulting debridement.1,13
The use of a fascia lata grafts in combination with an amni-
otic membrane graft after surgical debridement for infectious 
scleritis was used successfully by Zheng et al in two patients, 
one with Pseudomonas and one with fungal scleritis. Fascia 
lata was thought to be ideal because of its bioadaptability in 
size and thickness as well as its good cosmetic appearance. 
Prior to grafting, necrotic scleral tissue was removed and the 
surface was irrigated with ceftazidime. The fascia lata was 
then dissected from the biceps femoris in the leg and placed 
over the defect with an overlying amniotic membrane or 
pedicle conjunctival flap, with subconjunctival injection of Clinical Ophthalmology 2013:7 submit your manuscript | www.dovepress.com
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ceftazidime followed by oral cefdinir for 4 days. This was the 
only group to report the use of both a fascia lata and amni-
otic membrane grafts, and both patients showed evidence of 
resolution.44
Not unlike fascia lata grafts, tectonic scleral reinforce-
ment with preserved pericardium and donor corneal tissue 
was used successfully in a patient with nocardial scleritis 
that progressed to scleral perforation and uveal prolapse. 
This technique along with topical and oral antibiotics 
allowed salvaging of the eye and a final Snellen visual 
acuity of 20/70.36
A variety of medical modalities have been suggested as 
good adjunctive treatments to surgical debridement. These 
include systemic and topical antibiotics, subconjunctival 
injections of antibiotic at both ends of the scleral lesion, and 
wound irrigation with antibiotic solution one to two times a 
day followed by normal saline after improvement.22 Intraocular 
antibiotics should be used in all cases of endophthalmitis, and 
topical steroids should always be initiated only when antibiot-
ics have been reliably used for several days.13
Finally, Meallet proposed the use of continuous 
subpalpebral lavage antibiotics for the treatment of infectious 
scleritis, reporting resolution of all six cases of scleritis in 
this study after this treatment.12 However, this technique was 
complicated by hyphema and cataract formation as well as 
corneal thinning or dense corneal scar requiring corneal 
transplants, indicating that important adjustments have yet 
to be made to this technique. Additionally, the question of 
systemic absorption of this continuous antibiotic regimen 
was not adequately addressed.12
Outcomes
As may be expected after the discussion in this review, 
infectious scleritis has worse visual acuity after remission 
and longer resolution time as compared to noninfectious 
scleritis.15 Not surprisingly, isolated infectious scleritis has 
better prognosis than sclerokeratitis. Hodson et al reported 
that 50% of eyes in their study with infectious scleritis lost 
functional vision, indicating best corrected Snellen visual 
acuity less than 20/200.2
Poor prognostic indicators in infectious scleritis include a 
presenting vision worse than 20/200 or concomitant   keratitis 
or endophthalmitis, which tend to require enucleation or 
evisceration more commonly.2 Additionally, fungal etiologies 
tend to have worse prognosis, likely secondary to delays in 
diagnosis.15 However, there is no difference in duration of 
treatment or need for surgical debridement when comparing 
bacterial versus fungal cases.2 The degree of final vision loss 
does not significantly correlate with any specific inciting 
factor, infectious organism, nor the amount of time from 
symptom initiation to diagnosis. Rather, visual outcome only 
significantly correlates with low presenting vision.2
Hodson et al report that the median time between com-
mencing treatment and resolution of scleritis was 46 days 
with 50% of eyes losing functional vision.2 Only one case of 
recurrence was noted after cessation of treatment in this study 
after apparent full resolution.2 Though recurrences are noted 
commonly as new nodules or necrotic areas during active 
infectious scleritis, the appearance of such recurrences after 
achieving full resolution of scleritis is generally rare.2,41
Surgical debridement repeatedly resulted in much greater 
overall improvement in outcome. Sahu et al showed an improve-
ment in vision of greater than two lines in 60% of patients with 
use of concurrent debridements as needed.13 Reversible causes 
of vision loss include cataract, fibrotic pupillary membranes, 
repairable retinal detachments, and corneal opacities. Irrevers-
ible causes include chronic retinal and choroidal detachments, 
glaucoma, or the need for enucleation or evisceration.2,13
Conclusion
Infectious scleritis, though rare, is an important and immi-
nently vision-threatening cause of scleritis. Therefore, it 
is critical for eye care professionals to maintain infectious 
etiologies in their differential diagnosis for all patients 
with presenting symptoms of scleral hyperemia and sig-
nificant ocular pain. Of particular interest are patients with 
Figure 6 Scleral ulcer before and after debridement
Notes: (A) The scleral ulceration located at the 9 o’clock position. Severe congestion 
and subconjunctival abscess were noted at 10 o’clock position under the biomicroscope. 
(B) After the surgical debridement, the scleral wound was left open. in comparison 
with (A), the involved area was more extensive. (C) Ten days later, the debrided area 
was healing. © 1997 BMJ Publishing Group. Reproduced with permission from: Lin CP, 
Shih MH, Tsai MC. Clinical experiences of infectious scleral ulceration: a complication 
of pterygium operation. Br J Ophthalmol. 1997;81(11):980–983.22Clinical Ophthalmology 2013:7 submit your manuscript | www.dovepress.com
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a history of ocular surgery or trauma, regardless of how 
remote the event, as infections appear to remain dormant 
within the sclera for months to years before reactivation. 
In addition, patients’ refractory to treatment for presumed 
autoimmune scleritis should be promptly considered for 
infectious etiologies, as their immunosuppressive therapy 
will inevitably worsen their infection. Scleral abscesses and 
necrosis are common initial signs in infectious scleritis, 
though many patients will present with more advanced 
sequelae such as retinal or choroidal detachments and 
glaucoma. Bacterial, viral, and fungal etiologies exist for 
infectious scleritis, with Pseudomonas aeruginosa being 
the most common overall cause and fungi having the worst 
overall prognosis. Appropriate diagnosis generally requires 
scleral scrapings with thorough culturing and immunohis-
tochemical staining. However, empiric treatment may be 
necessary when these laboratory tests return inconclusive. 
The characteristics of presentation for specific microbes 
discussed in this review, along with ancillary tests such 
as ultrasound and optical coherence tomography, may 
facilitate appropriate diagnosis and therapy in these 
cases. Effective treatment of infectious scleritis requires 
both aggressive medical and surgical methods. In addi-
tion to microbe-specific medical therapy, repeat drainage 
and debridement of scleral abscesses and necrotic tissue 
with the use of various tissue grafts for scleral reinforce-
ment is necessary for resolution. Interestingly, the area of 
involved sclera is consistently larger intraoperatively than 
is initially judged on clinical exam, further supporting 
the importance of surgical exploration. About half of all 
patients with infectious scleritis maintain functional vision 
after resolution. Recurrences rarely occur, but highlight the 
importance of continued close observation for an extended 
period of time even after clinical resolution in patients with 
infectious scleritis. With proactive prevention, efficient 
diagnosis, prompt initiation of aggressive treatment, and 
close observation, patients with infectious scleritis may 
have better outcomes.
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